ST both demonstrated the benefit of CEA in neurologically symptomatic patients with carotid stenosis that reduced diameter ⬎50%.2-4 NASCET demonstrated an absolute risk reduction in stroke of 17% at 2 years (24% in
medical arm vs 7% in surgical arm) for patients with ⬎70%
carotid stenosis. ECST demonstrated a similar stroke risk in
this group after 3 years